Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.07
-15.62 (-7.01%)
AAPL  277.43
+1.52 (0.55%)
AMD  206.67
+14.17 (7.36%)
BAC  56.83
+1.89 (3.44%)
GOOG  324.95
-6.38 (-1.93%)
META  660.16
-10.05 (-1.50%)
MSFT  398.06
+4.39 (1.12%)
NVDA  184.53
+12.65 (7.36%)
ORCL  140.64
+4.16 (3.05%)
TSLA  412.43
+15.22 (3.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.